The Fibroid Foundation Corporation

Rockville, MD

UEI
MJHQEXNQPFR7
CAGE
9MFN6
Primary NAICS
813410 Civic and Social Organizations
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Woman Owned Business
  • Non-Profit Organization
  • Foundation
  • Black American Owned
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
1201 Seven Locks Rd #360, Rockville, MD 20854, USA
Founded
2013
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health & Wellness
SIC code
83 Social Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
Mayo Clinic COllaboration for EQuity in Uterine Leiomyomas - CPEO Core P50HD115283 $76,604
Mayo Clinic COllaboration for EQuity in Uterine Leiomyomas - CPEO Core P50HD115283 $33,352
Mayo Clinic Statement of Work Describe the nature of the collaboration with the Prime Awardee Principal Investigator: The Fibroid Foundation, under the leadership of… P50HD115283 $74,668
Mayo Clinic OVERALL COEQUaL, the COllaboration for EQuity in Uterine Leiomyomas, builds on longstanding collaborations among women with uterine fibroids (UF) and… P50HD115283 $94,604

Similar vendors

About the company

The Fibroid Foundation Corporation, doing business as The Fibroid Foundation, operates as a sub-recipient on federal research grants focused on uterine fibroid health equity, with all three recent awards flowing from the National Institute of Child Health and Human Development through prime grantee Mayo Clinic. The organization is a tax-exempt nonprofit corporation headquartered in Rockville, Maryland, designated as a minority-owned business and woman-owned business by SBA standards.

The Fibroid Foundation's federal footprint centers on patient advocacy, community partnership, education, and clinical research support for uterine fibroid treatment and health disparities. Under the leadership of Sateria Venable, the organization leads the Community Partnership, Education, and Outreach (CPEO) Core within the COllaboration for EQuity in Uterine Leiomyomas (COEEQUAL) initiative, reporting to Mayo Clinic Principal Investigator Dr. Elizabeth Stewart. The collaboration with Mayo Clinic dates to 2012 when the Foundation contributed to the COMPARE-UF Fibroid Registry in response to a PCORI/AHRQ funding opportunity. Current work involves three federal grant sub-awards from NICHD, all awarded through Mayo Clinic: the initial November 2024 COEEQUAL award establishing the research framework, a July 2025 sub-award detailing the CPEO Core's statement of work and collaborative scope, and a March 2026 award for continued CPEO Core operations. The Foundation's role encompasses multi-directional communication throughout the research process, targeted awareness and education on uterine fibroid treatment options, provider and insurer factor analysis, development of innovative tools to overcome care barriers, and dissemination via weekly briefings, alerts, podcasts, and multiple educational modalities. Combined obligated dollars across the three sub-awards total $203 thousand. Activity has remained steady at one award per year since late 2024, with the single customer agency (NICHD) accounting for 100% of recent awards.

Quick answers

Is The Fibroid Foundation Corporation registered in SAM.gov?

Yes. The Fibroid Foundation Corporation's SAM.gov registration is active through March 2, 2027.

On GovTribe

See The Fibroid Foundation Corporation's full federal record

  • Similar vendors